PCN2 AN INTERIM COST AND OUTCOME COMPARISON ALONGSIDE A PROSPECTIVE RANDOMIZED CLINICAL TRIAL COMPARING EARLY INTENSIFICATION WITH BONE MARROW TRANSPLANTATION (BMT) TO CONVENTIONAL DOSE CHEMOTHERAPY FOR PREVIOUSLY UNTREATED PATIENTS WITH AGGRESSIVE NON-HODGKIN's LYMPHOMA
| Autor: | KM King, AT Adamus, MA Rodriguez, RB Arbuckle |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
Oncology
medicine.medical_specialty Chemotherapy Bone marrow transplantation business.industry medicine.medical_treatment Health Policy Public Health Environmental and Occupational Health medicine.disease Non-Hodgkin's lymphoma law.invention Surgery Randomized controlled trial law Internal medicine Interim medicine business |
| Zdroj: | Value in Health. 5(3) |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/s1098-3015(10)60994-1 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect